
Lisa Roth
Director, Division of Pediatric Hematology–Oncology · NYU Grossman School of Medicine
Credentials: · ·
History
Research
American Journal of Obstetrics and Gynecology · 2006 · 52 citations
Treatment with rituximab in benign and malignant hematologic disorders in children
Review · The Journal of Pediatrics · 2007 · First of 4 authors · 50 citations
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
Blood · 2011 · First of 11 authors · 26 citations
- JB
2 papers
- WT
2 papers

1 paper
- AC
1 paper

1 paper

1 paper

1 paper

1 paper
Grants
- 2022–2027
B Cell Determinants of EBV Latency
National Cancer Institute · U01
PI · $4M · Weill Medical Coll of Cornell Univ
- 2022–2027
Targeting Latency Switch in EBV+ Lymphomas
National Cancer Institute · R37
Contact PI · $3.3M · New York University School of Medicine
- 2017–2021
Rational Translation of EZH2 Targeted Therapy in Germinal Center B-Cell Lymphoma
National Cancer Institute · K08
Contact PI · $684.5K · Weill Medical Coll of Cornell Univ



